BlackThorn Raises $76m To Personalize Medicines For Neurobehavioral Disorders
Jun 13 2019
•
By
Mandy Jackson
BlackThorn uses AI and machine learning to find neurobehavioral drug targets. • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Financing
More from Business
